nodes	percent_of_prediction	percent_of_DWPC	metapath
Levobupivacaine—CYP1A2—Gemfibrozil—coronary artery disease	0.0807	0.137	CbGbCtD
Levobupivacaine—CYP1A2—Clopidogrel—coronary artery disease	0.07	0.119	CbGbCtD
Levobupivacaine—CYP3A4—Ticagrelor—coronary artery disease	0.0593	0.101	CbGbCtD
Levobupivacaine—CYP3A4—Fenofibrate—coronary artery disease	0.0529	0.0896	CbGbCtD
Levobupivacaine—CYP3A4—Gemfibrozil—coronary artery disease	0.0423	0.0716	CbGbCtD
Levobupivacaine—CYP3A4—Clopidogrel—coronary artery disease	0.0367	0.0621	CbGbCtD
Levobupivacaine—CYP1A2—Losartan—coronary artery disease	0.0342	0.0579	CbGbCtD
Levobupivacaine—CYP3A4—Eplerenone—coronary artery disease	0.0341	0.0577	CbGbCtD
Levobupivacaine—CYP3A4—Enalapril—coronary artery disease	0.0304	0.0515	CbGbCtD
Levobupivacaine—CYP3A4—Rosuvastatin—coronary artery disease	0.0236	0.04	CbGbCtD
Levobupivacaine—CYP3A4—Ezetimibe—coronary artery disease	0.0236	0.04	CbGbCtD
Levobupivacaine—CYP3A4—Simvastatin—coronary artery disease	0.022	0.0372	CbGbCtD
Levobupivacaine—CYP3A4—Pravastatin—coronary artery disease	0.0215	0.0364	CbGbCtD
Levobupivacaine—CYP3A4—Lovastatin—coronary artery disease	0.0215	0.0364	CbGbCtD
Levobupivacaine—CYP3A4—Atorvastatin—coronary artery disease	0.0196	0.0332	CbGbCtD
Levobupivacaine—CYP3A4—Losartan—coronary artery disease	0.0179	0.0303	CbGbCtD
Levobupivacaine—Bupivacaine—CYP2C19—coronary artery disease	0.000177	0.704	CrCbGaD
Levobupivacaine—Loss of consciousness—Timolol—coronary artery disease	0.000138	0.000383	CcSEcCtD
Levobupivacaine—Decreased appetite—Furosemide—coronary artery disease	0.000138	0.000383	CcSEcCtD
Levobupivacaine—Headache—Fenofibrate—coronary artery disease	0.000137	0.000381	CcSEcCtD
Levobupivacaine—Vision blurred—Lisinopril—coronary artery disease	0.000137	0.000381	CcSEcCtD
Levobupivacaine—Paraesthesia—Losartan—coronary artery disease	0.000137	0.000381	CcSEcCtD
Levobupivacaine—Gastrointestinal pain—Captopril—coronary artery disease	0.000137	0.000381	CcSEcCtD
Levobupivacaine—Urticaria—Telmisartan—coronary artery disease	0.000137	0.000381	CcSEcCtD
Levobupivacaine—Cough—Timolol—coronary artery disease	0.000137	0.000381	CcSEcCtD
Levobupivacaine—Vomiting—Clopidogrel—coronary artery disease	0.000137	0.000381	CcSEcCtD
Levobupivacaine—Diarrhoea—Simvastatin—coronary artery disease	0.000137	0.000381	CcSEcCtD
Levobupivacaine—Gastrointestinal disorder—Furosemide—coronary artery disease	0.000137	0.00038	CcSEcCtD
Levobupivacaine—Arthralgia—Ramipril—coronary artery disease	0.000137	0.00038	CcSEcCtD
Levobupivacaine—Tremor—Lisinopril—coronary artery disease	0.000137	0.000379	CcSEcCtD
Levobupivacaine—Abdominal pain—Telmisartan—coronary artery disease	0.000137	0.000379	CcSEcCtD
Levobupivacaine—Body temperature increased—Telmisartan—coronary artery disease	0.000137	0.000379	CcSEcCtD
Levobupivacaine—Dyspnoea—Losartan—coronary artery disease	0.000136	0.000379	CcSEcCtD
Levobupivacaine—Anxiety—Ramipril—coronary artery disease	0.000136	0.000379	CcSEcCtD
Levobupivacaine—Vomiting—Lovastatin—coronary artery disease	0.000136	0.000378	CcSEcCtD
Levobupivacaine—Somnolence—Losartan—coronary artery disease	0.000136	0.000378	CcSEcCtD
Levobupivacaine—Dizziness—Eplerenone—coronary artery disease	0.000136	0.000377	CcSEcCtD
Levobupivacaine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	0.000136	0.000377	CcSEcCtD
Levobupivacaine—Asthenia—Valsartan—coronary artery disease	0.000136	0.000377	CcSEcCtD
Levobupivacaine—Hypertension—Timolol—coronary artery disease	0.000136	0.000377	CcSEcCtD
Levobupivacaine—Pain—Furosemide—coronary artery disease	0.000136	0.000376	CcSEcCtD
Levobupivacaine—Constipation—Furosemide—coronary artery disease	0.000136	0.000376	CcSEcCtD
Levobupivacaine—Hypersensitivity—Niacin—coronary artery disease	0.000136	0.000376	CcSEcCtD
Levobupivacaine—Asthenia—Olmesartan—coronary artery disease	0.000135	0.000375	CcSEcCtD
Levobupivacaine—Headache—Clopidogrel—coronary artery disease	0.000135	0.000375	CcSEcCtD
Levobupivacaine—Anaemia—Lisinopril—coronary artery disease	0.000135	0.000374	CcSEcCtD
Levobupivacaine—Dyspepsia—Losartan—coronary artery disease	0.000135	0.000374	CcSEcCtD
Levobupivacaine—Feeling abnormal—Perindopril—coronary artery disease	0.000134	0.000373	CcSEcCtD
Levobupivacaine—Headache—Lovastatin—coronary artery disease	0.000134	0.000373	CcSEcCtD
Levobupivacaine—Pruritus—Valsartan—coronary artery disease	0.000134	0.000372	CcSEcCtD
Levobupivacaine—Arthralgia—Timolol—coronary artery disease	0.000134	0.000371	CcSEcCtD
Levobupivacaine—Vomiting—Ezetimibe—coronary artery disease	0.000134	0.000371	CcSEcCtD
Levobupivacaine—Hypersensitivity—Pravastatin—coronary artery disease	0.000133	0.00037	CcSEcCtD
Levobupivacaine—Gastrointestinal pain—Perindopril—coronary artery disease	0.000133	0.00037	CcSEcCtD
Levobupivacaine—Anxiety—Timolol—coronary artery disease	0.000133	0.00037	CcSEcCtD
Levobupivacaine—Angioedema—Lisinopril—coronary artery disease	0.000133	0.00037	CcSEcCtD
Levobupivacaine—Pruritus—Olmesartan—coronary artery disease	0.000133	0.00037	CcSEcCtD
Levobupivacaine—Decreased appetite—Losartan—coronary artery disease	0.000133	0.000369	CcSEcCtD
Levobupivacaine—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	0.000133	0.000369	CcSEcCtD
Levobupivacaine—Abdominal pain—Captopril—coronary artery disease	0.000133	0.000369	CcSEcCtD
Levobupivacaine—Body temperature increased—Captopril—coronary artery disease	0.000133	0.000369	CcSEcCtD
Levobupivacaine—Dizziness—Simvastatin—coronary artery disease	0.000133	0.000368	CcSEcCtD
Levobupivacaine—Confusional state—Ramipril—coronary artery disease	0.000132	0.000367	CcSEcCtD
Levobupivacaine—Asthenia—Niacin—coronary artery disease	0.000132	0.000366	CcSEcCtD
Levobupivacaine—Headache—Ezetimibe—coronary artery disease	0.000132	0.000365	CcSEcCtD
Levobupivacaine—Oedema—Ramipril—coronary artery disease	0.000131	0.000364	CcSEcCtD
Levobupivacaine—Anaphylactic shock—Ramipril—coronary artery disease	0.000131	0.000364	CcSEcCtD
Levobupivacaine—Pain—Losartan—coronary artery disease	0.000131	0.000363	CcSEcCtD
Levobupivacaine—Constipation—Losartan—coronary artery disease	0.000131	0.000363	CcSEcCtD
Levobupivacaine—Syncope—Lisinopril—coronary artery disease	0.000131	0.000363	CcSEcCtD
Levobupivacaine—Vomiting—Eplerenone—coronary artery disease	0.000131	0.000363	CcSEcCtD
Levobupivacaine—Feeling abnormal—Furosemide—coronary artery disease	0.000131	0.000363	CcSEcCtD
Levobupivacaine—Nausea—Fenofibrate—coronary artery disease	0.00013	0.000362	CcSEcCtD
Levobupivacaine—Pruritus—Niacin—coronary artery disease	0.00013	0.000361	CcSEcCtD
Levobupivacaine—Asthenia—Pravastatin—coronary artery disease	0.00013	0.000361	CcSEcCtD
Levobupivacaine—Gastrointestinal pain—Furosemide—coronary artery disease	0.00013	0.00036	CcSEcCtD
Levobupivacaine—Urticaria—Perindopril—coronary artery disease	0.00013	0.00036	CcSEcCtD
Levobupivacaine—Hypersensitivity—Trandolapril—coronary artery disease	0.00013	0.00036	CcSEcCtD
Levobupivacaine—Diarrhoea—Valsartan—coronary artery disease	0.000129	0.000359	CcSEcCtD
Levobupivacaine—Confusional state—Timolol—coronary artery disease	0.000129	0.000359	CcSEcCtD
Levobupivacaine—Shock—Ramipril—coronary artery disease	0.000129	0.000358	CcSEcCtD
Levobupivacaine—Hypersensitivity—Enalapril—coronary artery disease	0.000129	0.000358	CcSEcCtD
Levobupivacaine—Abdominal pain—Perindopril—coronary artery disease	0.000129	0.000358	CcSEcCtD
Levobupivacaine—Body temperature increased—Perindopril—coronary artery disease	0.000129	0.000358	CcSEcCtD
Levobupivacaine—Palpitations—Lisinopril—coronary artery disease	0.000129	0.000358	CcSEcCtD
Levobupivacaine—Diarrhoea—Olmesartan—coronary artery disease	0.000129	0.000358	CcSEcCtD
Levobupivacaine—Headache—Eplerenone—coronary artery disease	0.000129	0.000358	CcSEcCtD
Levobupivacaine—Nervous system disorder—Ramipril—coronary artery disease	0.000129	0.000357	CcSEcCtD
Levobupivacaine—Oedema—Timolol—coronary artery disease	0.000128	0.000356	CcSEcCtD
Levobupivacaine—Anaphylactic shock—Timolol—coronary artery disease	0.000128	0.000356	CcSEcCtD
Levobupivacaine—Pruritus—Pravastatin—coronary artery disease	0.000128	0.000356	CcSEcCtD
Levobupivacaine—Loss of consciousness—Lisinopril—coronary artery disease	0.000128	0.000356	CcSEcCtD
Levobupivacaine—Nausea—Clopidogrel—coronary artery disease	0.000128	0.000356	CcSEcCtD
Levobupivacaine—Tachycardia—Ramipril—coronary artery disease	0.000128	0.000355	CcSEcCtD
Levobupivacaine—Skin disorder—Ramipril—coronary artery disease	0.000127	0.000354	CcSEcCtD
Levobupivacaine—Infection—Timolol—coronary artery disease	0.000127	0.000354	CcSEcCtD
Levobupivacaine—Vomiting—Simvastatin—coronary artery disease	0.000127	0.000354	CcSEcCtD
Levobupivacaine—Hypersensitivity—Telmisartan—coronary artery disease	0.000127	0.000353	CcSEcCtD
Levobupivacaine—Cough—Lisinopril—coronary artery disease	0.000127	0.000353	CcSEcCtD
Levobupivacaine—Nausea—Lovastatin—coronary artery disease	0.000127	0.000353	CcSEcCtD
Levobupivacaine—Hyperhidrosis—Ramipril—coronary artery disease	0.000127	0.000352	CcSEcCtD
Levobupivacaine—Asthenia—Trandolapril—coronary artery disease	0.000126	0.00035	CcSEcCtD
Levobupivacaine—Shock—Timolol—coronary artery disease	0.000126	0.00035	CcSEcCtD
Levobupivacaine—Feeling abnormal—Losartan—coronary artery disease	0.000126	0.00035	CcSEcCtD
Levobupivacaine—Urticaria—Furosemide—coronary artery disease	0.000126	0.00035	CcSEcCtD
Levobupivacaine—Diarrhoea—Niacin—coronary artery disease	0.000126	0.000349	CcSEcCtD
Levobupivacaine—Nervous system disorder—Timolol—coronary artery disease	0.000126	0.000349	CcSEcCtD
Levobupivacaine—Asthenia—Enalapril—coronary artery disease	0.000126	0.000349	CcSEcCtD
Levobupivacaine—Headache—Simvastatin—coronary artery disease	0.000126	0.000348	CcSEcCtD
Levobupivacaine—Abdominal pain—Furosemide—coronary artery disease	0.000125	0.000348	CcSEcCtD
Levobupivacaine—Body temperature increased—Furosemide—coronary artery disease	0.000125	0.000348	CcSEcCtD
Levobupivacaine—Gastrointestinal pain—Losartan—coronary artery disease	0.000125	0.000347	CcSEcCtD
Levobupivacaine—Dizziness—Valsartan—coronary artery disease	0.000125	0.000347	CcSEcCtD
Levobupivacaine—Nausea—Ezetimibe—coronary artery disease	0.000125	0.000346	CcSEcCtD
Levobupivacaine—Skin disorder—Timolol—coronary artery disease	0.000125	0.000346	CcSEcCtD
Levobupivacaine—Dizziness—Olmesartan—coronary artery disease	0.000125	0.000346	CcSEcCtD
Levobupivacaine—Pruritus—Trandolapril—coronary artery disease	0.000124	0.000345	CcSEcCtD
Levobupivacaine—Arthralgia—Lisinopril—coronary artery disease	0.000124	0.000345	CcSEcCtD
Levobupivacaine—Hyperhidrosis—Timolol—coronary artery disease	0.000124	0.000344	CcSEcCtD
Levobupivacaine—Asthenia—Telmisartan—coronary artery disease	0.000124	0.000344	CcSEcCtD
Levobupivacaine—Pruritus—Enalapril—coronary artery disease	0.000124	0.000344	CcSEcCtD
Levobupivacaine—Diarrhoea—Pravastatin—coronary artery disease	0.000124	0.000344	CcSEcCtD
Levobupivacaine—Anxiety—Lisinopril—coronary artery disease	0.000124	0.000343	CcSEcCtD
Levobupivacaine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	0.000123	0.000342	CcSEcCtD
Levobupivacaine—Hypotension—Ramipril—coronary artery disease	0.000123	0.00034	CcSEcCtD
Levobupivacaine—Pruritus—Telmisartan—coronary artery disease	0.000122	0.000339	CcSEcCtD
Levobupivacaine—Nausea—Eplerenone—coronary artery disease	0.000122	0.000339	CcSEcCtD
Levobupivacaine—Dizziness—Niacin—coronary artery disease	0.000122	0.000338	CcSEcCtD
Levobupivacaine—Urticaria—Losartan—coronary artery disease	0.000122	0.000337	CcSEcCtD
Levobupivacaine—Body temperature increased—Losartan—coronary artery disease	0.000121	0.000336	CcSEcCtD
Levobupivacaine—Abdominal pain—Losartan—coronary artery disease	0.000121	0.000336	CcSEcCtD
Levobupivacaine—Asthenia—Captopril—coronary artery disease	0.000121	0.000335	CcSEcCtD
Levobupivacaine—Diarrhoea—Trandolapril—coronary artery disease	0.00012	0.000334	CcSEcCtD
Levobupivacaine—Vomiting—Valsartan—coronary artery disease	0.00012	0.000334	CcSEcCtD
Levobupivacaine—Confusional state—Lisinopril—coronary artery disease	0.00012	0.000333	CcSEcCtD
Levobupivacaine—Diarrhoea—Enalapril—coronary artery disease	0.00012	0.000333	CcSEcCtD
Levobupivacaine—Hypotension—Timolol—coronary artery disease	0.00012	0.000333	CcSEcCtD
Levobupivacaine—Dizziness—Pravastatin—coronary artery disease	0.00012	0.000333	CcSEcCtD
Levobupivacaine—Vomiting—Olmesartan—coronary artery disease	0.00012	0.000332	CcSEcCtD
Levobupivacaine—Musculoskeletal discomfort—Ramipril—coronary artery disease	0.00012	0.000332	CcSEcCtD
Levobupivacaine—Nausea—Simvastatin—coronary artery disease	0.000119	0.00033	CcSEcCtD
Levobupivacaine—Anaphylactic shock—Lisinopril—coronary artery disease	0.000119	0.00033	CcSEcCtD
Levobupivacaine—Oedema—Lisinopril—coronary artery disease	0.000119	0.00033	CcSEcCtD
Levobupivacaine—Pruritus—Captopril—coronary artery disease	0.000119	0.00033	CcSEcCtD
Levobupivacaine—Insomnia—Ramipril—coronary artery disease	0.000119	0.000329	CcSEcCtD
Levobupivacaine—Headache—Valsartan—coronary artery disease	0.000119	0.000329	CcSEcCtD
Levobupivacaine—Diarrhoea—Telmisartan—coronary artery disease	0.000118	0.000328	CcSEcCtD
Levobupivacaine—Infection—Lisinopril—coronary artery disease	0.000118	0.000328	CcSEcCtD
Levobupivacaine—Headache—Olmesartan—coronary artery disease	0.000118	0.000327	CcSEcCtD
Levobupivacaine—Paraesthesia—Ramipril—coronary artery disease	0.000118	0.000327	CcSEcCtD
Levobupivacaine—Shock—Lisinopril—coronary artery disease	0.000117	0.000325	CcSEcCtD
Levobupivacaine—Asthenia—Perindopril—coronary artery disease	0.000117	0.000325	CcSEcCtD
Levobupivacaine—Dyspnoea—Ramipril—coronary artery disease	0.000117	0.000325	CcSEcCtD
Levobupivacaine—Vomiting—Niacin—coronary artery disease	0.000117	0.000325	CcSEcCtD
Levobupivacaine—Musculoskeletal discomfort—Timolol—coronary artery disease	0.000117	0.000324	CcSEcCtD
Levobupivacaine—Hypersensitivity—Furosemide—coronary artery disease	0.000117	0.000324	CcSEcCtD
Levobupivacaine—Somnolence—Ramipril—coronary artery disease	0.000117	0.000324	CcSEcCtD
Levobupivacaine—Dizziness—Trandolapril—coronary artery disease	0.000116	0.000323	CcSEcCtD
Levobupivacaine—Tachycardia—Lisinopril—coronary artery disease	0.000116	0.000322	CcSEcCtD
Levobupivacaine—Insomnia—Timolol—coronary artery disease	0.000116	0.000322	CcSEcCtD
Levobupivacaine—Dizziness—Enalapril—coronary artery disease	0.000116	0.000322	CcSEcCtD
Levobupivacaine—Skin disorder—Lisinopril—coronary artery disease	0.000116	0.000321	CcSEcCtD
Levobupivacaine—Dyspepsia—Ramipril—coronary artery disease	0.000116	0.000321	CcSEcCtD
Levobupivacaine—Pruritus—Perindopril—coronary artery disease	0.000115	0.00032	CcSEcCtD
Levobupivacaine—Headache—Niacin—coronary artery disease	0.000115	0.00032	CcSEcCtD
Levobupivacaine—Paraesthesia—Timolol—coronary artery disease	0.000115	0.00032	CcSEcCtD
Levobupivacaine—Vomiting—Pravastatin—coronary artery disease	0.000115	0.00032	CcSEcCtD
Levobupivacaine—Hyperhidrosis—Lisinopril—coronary artery disease	0.000115	0.000319	CcSEcCtD
Levobupivacaine—Diarrhoea—Captopril—coronary artery disease	0.000115	0.000319	CcSEcCtD
Levobupivacaine—Dyspnoea—Timolol—coronary artery disease	0.000114	0.000317	CcSEcCtD
Levobupivacaine—Dizziness—Telmisartan—coronary artery disease	0.000114	0.000317	CcSEcCtD
Levobupivacaine—Decreased appetite—Ramipril—coronary artery disease	0.000114	0.000317	CcSEcCtD
Levobupivacaine—Somnolence—Timolol—coronary artery disease	0.000114	0.000317	CcSEcCtD
Levobupivacaine—Asthenia—Furosemide—coronary artery disease	0.000114	0.000316	CcSEcCtD
Levobupivacaine—Headache—Pravastatin—coronary artery disease	0.000114	0.000315	CcSEcCtD
Levobupivacaine—Gastrointestinal disorder—Ramipril—coronary artery disease	0.000113	0.000314	CcSEcCtD
Levobupivacaine—Dyspepsia—Timolol—coronary artery disease	0.000113	0.000313	CcSEcCtD
Levobupivacaine—Hypersensitivity—Losartan—coronary artery disease	0.000113	0.000313	CcSEcCtD
Levobupivacaine—Nausea—Valsartan—coronary artery disease	0.000112	0.000312	CcSEcCtD
Levobupivacaine—Pruritus—Furosemide—coronary artery disease	0.000112	0.000311	CcSEcCtD
Levobupivacaine—Constipation—Ramipril—coronary artery disease	0.000112	0.000311	CcSEcCtD
Levobupivacaine—Nausea—Olmesartan—coronary artery disease	0.000112	0.00031	CcSEcCtD
Levobupivacaine—Vomiting—Trandolapril—coronary artery disease	0.000112	0.00031	CcSEcCtD
Levobupivacaine—Diarrhoea—Perindopril—coronary artery disease	0.000112	0.00031	CcSEcCtD
Levobupivacaine—Decreased appetite—Timolol—coronary artery disease	0.000112	0.00031	CcSEcCtD
Levobupivacaine—Vomiting—Enalapril—coronary artery disease	0.000111	0.000309	CcSEcCtD
Levobupivacaine—Hypotension—Lisinopril—coronary artery disease	0.000111	0.000309	CcSEcCtD
Levobupivacaine—Dizziness—Captopril—coronary artery disease	0.000111	0.000308	CcSEcCtD
Levobupivacaine—Gastrointestinal disorder—Timolol—coronary artery disease	0.000111	0.000307	CcSEcCtD
Levobupivacaine—Headache—Trandolapril—coronary artery disease	0.00011	0.000306	CcSEcCtD
Levobupivacaine—Vomiting—Telmisartan—coronary artery disease	0.00011	0.000305	CcSEcCtD
Levobupivacaine—Asthenia—Losartan—coronary artery disease	0.00011	0.000305	CcSEcCtD
Levobupivacaine—Headache—Enalapril—coronary artery disease	0.00011	0.000305	CcSEcCtD
Levobupivacaine—Pain—Timolol—coronary artery disease	0.00011	0.000305	CcSEcCtD
Levobupivacaine—Nausea—Niacin—coronary artery disease	0.000109	0.000303	CcSEcCtD
Levobupivacaine—Diarrhoea—Furosemide—coronary artery disease	0.000109	0.000301	CcSEcCtD
Levobupivacaine—Musculoskeletal discomfort—Lisinopril—coronary artery disease	0.000108	0.000301	CcSEcCtD
Levobupivacaine—Pruritus—Losartan—coronary artery disease	0.000108	0.000301	CcSEcCtD
Levobupivacaine—Headache—Telmisartan—coronary artery disease	0.000108	0.000301	CcSEcCtD
Levobupivacaine—Feeling abnormal—Ramipril—coronary artery disease	0.000108	0.0003	CcSEcCtD
Levobupivacaine—Dizziness—Perindopril—coronary artery disease	0.000108	0.000299	CcSEcCtD
Levobupivacaine—Insomnia—Lisinopril—coronary artery disease	0.000108	0.000299	CcSEcCtD
Levobupivacaine—Nausea—Pravastatin—coronary artery disease	0.000108	0.000299	CcSEcCtD
Levobupivacaine—Gastrointestinal pain—Ramipril—coronary artery disease	0.000107	0.000298	CcSEcCtD
Levobupivacaine—Paraesthesia—Lisinopril—coronary artery disease	0.000107	0.000297	CcSEcCtD
Levobupivacaine—Vomiting—Captopril—coronary artery disease	0.000107	0.000297	CcSEcCtD
Levobupivacaine—Dyspnoea—Lisinopril—coronary artery disease	0.000106	0.000295	CcSEcCtD
Levobupivacaine—Somnolence—Lisinopril—coronary artery disease	0.000106	0.000294	CcSEcCtD
Levobupivacaine—Feeling abnormal—Timolol—coronary artery disease	0.000106	0.000293	CcSEcCtD
Levobupivacaine—Headache—Captopril—coronary artery disease	0.000105	0.000292	CcSEcCtD
Levobupivacaine—Gastrointestinal pain—Timolol—coronary artery disease	0.000105	0.000291	CcSEcCtD
Levobupivacaine—Dizziness—Furosemide—coronary artery disease	0.000105	0.000291	CcSEcCtD
Levobupivacaine—Dyspepsia—Lisinopril—coronary artery disease	0.000105	0.000291	CcSEcCtD
Levobupivacaine—Diarrhoea—Losartan—coronary artery disease	0.000105	0.000291	CcSEcCtD
Levobupivacaine—Nausea—Trandolapril—coronary artery disease	0.000105	0.00029	CcSEcCtD
Levobupivacaine—Urticaria—Ramipril—coronary artery disease	0.000104	0.000289	CcSEcCtD
Levobupivacaine—Nausea—Enalapril—coronary artery disease	0.000104	0.000289	CcSEcCtD
Levobupivacaine—Vomiting—Perindopril—coronary artery disease	0.000104	0.000288	CcSEcCtD
Levobupivacaine—Body temperature increased—Ramipril—coronary artery disease	0.000104	0.000288	CcSEcCtD
Levobupivacaine—Abdominal pain—Ramipril—coronary artery disease	0.000104	0.000288	CcSEcCtD
Levobupivacaine—Decreased appetite—Lisinopril—coronary artery disease	0.000103	0.000287	CcSEcCtD
Levobupivacaine—Gastrointestinal disorder—Lisinopril—coronary artery disease	0.000103	0.000285	CcSEcCtD
Levobupivacaine—Nausea—Telmisartan—coronary artery disease	0.000103	0.000285	CcSEcCtD
Levobupivacaine—Headache—Perindopril—coronary artery disease	0.000102	0.000284	CcSEcCtD
Levobupivacaine—Urticaria—Timolol—coronary artery disease	0.000102	0.000283	CcSEcCtD
Levobupivacaine—Pain—Lisinopril—coronary artery disease	0.000102	0.000282	CcSEcCtD
Levobupivacaine—Constipation—Lisinopril—coronary artery disease	0.000102	0.000282	CcSEcCtD
Levobupivacaine—Body temperature increased—Timolol—coronary artery disease	0.000101	0.000281	CcSEcCtD
Levobupivacaine—Abdominal pain—Timolol—coronary artery disease	0.000101	0.000281	CcSEcCtD
Levobupivacaine—Dizziness—Losartan—coronary artery disease	0.000101	0.000281	CcSEcCtD
Levobupivacaine—Vomiting—Furosemide—coronary artery disease	0.000101	0.00028	CcSEcCtD
Levobupivacaine—Nausea—Captopril—coronary artery disease	9.98e-05	0.000277	CcSEcCtD
Levobupivacaine—Headache—Furosemide—coronary artery disease	9.94e-05	0.000276	CcSEcCtD
Levobupivacaine—Feeling abnormal—Lisinopril—coronary artery disease	9.81e-05	0.000272	CcSEcCtD
Levobupivacaine—Gastrointestinal pain—Lisinopril—coronary artery disease	9.73e-05	0.00027	CcSEcCtD
Levobupivacaine—Vomiting—Losartan—coronary artery disease	9.73e-05	0.00027	CcSEcCtD
Levobupivacaine—Nausea—Perindopril—coronary artery disease	9.69e-05	0.000269	CcSEcCtD
Levobupivacaine—Hypersensitivity—Ramipril—coronary artery disease	9.67e-05	0.000268	CcSEcCtD
Levobupivacaine—Headache—Losartan—coronary artery disease	9.59e-05	0.000266	CcSEcCtD
Levobupivacaine—Urticaria—Lisinopril—coronary artery disease	9.46e-05	0.000262	CcSEcCtD
Levobupivacaine—Hypersensitivity—Timolol—coronary artery disease	9.45e-05	0.000262	CcSEcCtD
Levobupivacaine—Nausea—Furosemide—coronary artery disease	9.42e-05	0.000262	CcSEcCtD
Levobupivacaine—Asthenia—Ramipril—coronary artery disease	9.42e-05	0.000261	CcSEcCtD
Levobupivacaine—Abdominal pain—Lisinopril—coronary artery disease	9.41e-05	0.000261	CcSEcCtD
Levobupivacaine—Body temperature increased—Lisinopril—coronary artery disease	9.41e-05	0.000261	CcSEcCtD
Levobupivacaine—Pruritus—Ramipril—coronary artery disease	9.29e-05	0.000258	CcSEcCtD
Levobupivacaine—Asthenia—Timolol—coronary artery disease	9.21e-05	0.000255	CcSEcCtD
Levobupivacaine—Nausea—Losartan—coronary artery disease	9.09e-05	0.000252	CcSEcCtD
Levobupivacaine—Pruritus—Timolol—coronary artery disease	9.08e-05	0.000252	CcSEcCtD
Levobupivacaine—Diarrhoea—Ramipril—coronary artery disease	8.98e-05	0.000249	CcSEcCtD
Levobupivacaine—Diarrhoea—Timolol—coronary artery disease	8.78e-05	0.000244	CcSEcCtD
Levobupivacaine—Hypersensitivity—Lisinopril—coronary artery disease	8.77e-05	0.000243	CcSEcCtD
Levobupivacaine—Dizziness—Ramipril—coronary artery disease	8.68e-05	0.000241	CcSEcCtD
Levobupivacaine—Asthenia—Lisinopril—coronary artery disease	8.54e-05	0.000237	CcSEcCtD
Levobupivacaine—Dizziness—Timolol—coronary artery disease	8.49e-05	0.000235	CcSEcCtD
Levobupivacaine—Pruritus—Lisinopril—coronary artery disease	8.42e-05	0.000234	CcSEcCtD
Levobupivacaine—Vomiting—Ramipril—coronary artery disease	8.35e-05	0.000232	CcSEcCtD
Levobupivacaine—Headache—Ramipril—coronary artery disease	8.22e-05	0.000228	CcSEcCtD
Levobupivacaine—Vomiting—Timolol—coronary artery disease	8.16e-05	0.000226	CcSEcCtD
Levobupivacaine—Diarrhoea—Lisinopril—coronary artery disease	8.14e-05	0.000226	CcSEcCtD
Levobupivacaine—Headache—Timolol—coronary artery disease	8.04e-05	0.000223	CcSEcCtD
Levobupivacaine—Dizziness—Lisinopril—coronary artery disease	7.87e-05	0.000218	CcSEcCtD
Levobupivacaine—Nausea—Ramipril—coronary artery disease	7.8e-05	0.000216	CcSEcCtD
Levobupivacaine—Nausea—Timolol—coronary artery disease	7.62e-05	0.000212	CcSEcCtD
Levobupivacaine—Vomiting—Lisinopril—coronary artery disease	7.57e-05	0.00021	CcSEcCtD
Levobupivacaine—Headache—Lisinopril—coronary artery disease	7.46e-05	0.000207	CcSEcCtD
Levobupivacaine—Tocainide—ALB—coronary artery disease	7.44e-05	0.296	CrCbGaD
Levobupivacaine—Nausea—Lisinopril—coronary artery disease	7.07e-05	0.000196	CcSEcCtD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—HADH—coronary artery disease	3e-05	0.000609	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—ARNTL—coronary artery disease	3e-05	0.000609	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CA5B—coronary artery disease	2.96e-05	0.000601	CbGpPWpGaD
Levobupivacaine—CYP3A4—Biological oxidations—GSTP1—coronary artery disease	2.93e-05	0.000595	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metapathway biotransformation—GSTP1—coronary artery disease	2.89e-05	0.000586	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—APOA2—coronary artery disease	2.84e-05	0.000577	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G2A—coronary artery disease	2.84e-05	0.000577	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—GPX2—coronary artery disease	2.84e-05	0.000577	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—GPX4—coronary artery disease	2.81e-05	0.00057	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—ABCG5—coronary artery disease	2.81e-05	0.00057	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—HADHA—coronary artery disease	2.78e-05	0.000563	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—LPA—coronary artery disease	2.71e-05	0.00055	CbGpPWpGaD
Levobupivacaine—CYP3A4—Biological oxidations—GSTM1—coronary artery disease	2.69e-05	0.000546	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PPAP2B—coronary artery disease	2.66e-05	0.00054	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CKM—coronary artery disease	2.66e-05	0.00054	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—UQCRFS1—coronary artery disease	2.66e-05	0.00054	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metapathway biotransformation—GSTM1—coronary artery disease	2.66e-05	0.000539	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—APOA5—coronary artery disease	2.6e-05	0.000528	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—IL6—coronary artery disease	2.58e-05	0.000523	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—P4HB—coronary artery disease	2.55e-05	0.000518	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CKMT1B—coronary artery disease	2.52e-05	0.000511	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G1B—coronary artery disease	2.5e-05	0.000508	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—IL6—coronary artery disease	2.48e-05	0.000504	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—SULT4A1—coronary artery disease	2.47e-05	0.000502	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PYGM—coronary artery disease	2.47e-05	0.000502	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PDK4—coronary artery disease	2.47e-05	0.000502	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ALDH6A1—coronary artery disease	2.47e-05	0.000502	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CKMT2—coronary artery disease	2.47e-05	0.000502	CbGpPWpGaD
Levobupivacaine—CYP1A2—Biological oxidations—POMC—coronary artery disease	2.47e-05	0.0005	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—AKT1—coronary artery disease	2.38e-05	0.000482	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—AKT1—coronary artery disease	2.29e-05	0.000465	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PFKM—coronary artery disease	2.2e-05	0.000447	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GK—coronary artery disease	2.2e-05	0.000447	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GYG1—coronary artery disease	2.2e-05	0.000447	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—HMGCS2—coronary artery disease	2.2e-05	0.000447	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—LDHA—coronary artery disease	2.2e-05	0.000447	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GATM—coronary artery disease	2.2e-05	0.000447	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—coronary artery disease	2.15e-05	0.000437	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C19—coronary artery disease	2.15e-05	0.000437	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3C2A—coronary artery disease	2.15e-05	0.000437	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—APOC3—coronary artery disease	2.14e-05	0.000435	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—LDLR—coronary artery disease	2.13e-05	0.000432	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GCH1—coronary artery disease	2.1e-05	0.000427	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—AK1—coronary artery disease	2.1e-05	0.000427	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CETP—coronary artery disease	2.08e-05	0.000422	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—SDC1—coronary artery disease	2.06e-05	0.000417	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CKM—coronary artery disease	2.05e-05	0.000417	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—UQCRFS1—coronary artery disease	2.05e-05	0.000417	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PPAP2B—coronary artery disease	2.05e-05	0.000417	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—MDH2—coronary artery disease	2.02e-05	0.000409	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—UGCG—coronary artery disease	2.02e-05	0.000409	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PPAT—coronary artery disease	2.02e-05	0.000409	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PLCD1—coronary artery disease	2.02e-05	0.000409	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PGM1—coronary artery disease	1.94e-05	0.000394	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PDK4—coronary artery disease	1.91e-05	0.000387	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—SULT4A1—coronary artery disease	1.91e-05	0.000387	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CKMT2—coronary artery disease	1.91e-05	0.000387	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PYGM—coronary artery disease	1.91e-05	0.000387	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ALDH6A1—coronary artery disease	1.91e-05	0.000387	CbGpPWpGaD
Levobupivacaine—CYP3A4—Biological oxidations—POMC—coronary artery disease	1.9e-05	0.000386	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—coronary artery disease	1.9e-05	0.000385	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—coronary artery disease	1.88e-05	0.000382	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PYGB—coronary artery disease	1.87e-05	0.00038	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CKB—coronary artery disease	1.87e-05	0.00038	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—DLAT—coronary artery disease	1.76e-05	0.000358	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PFKFB3—coronary artery disease	1.76e-05	0.000358	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—COX5B—coronary artery disease	1.76e-05	0.000358	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GSTM2—coronary artery disease	1.76e-05	0.000358	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PLIN1—coronary artery disease	1.76e-05	0.000358	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GYG1—coronary artery disease	1.7e-05	0.000345	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PFKM—coronary artery disease	1.7e-05	0.000345	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—LDHA—coronary artery disease	1.7e-05	0.000345	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GK—coronary artery disease	1.7e-05	0.000345	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GATM—coronary artery disease	1.7e-05	0.000345	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—HMGCS2—coronary artery disease	1.7e-05	0.000345	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—coronary artery disease	1.68e-05	0.00034	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—SULT1E1—coronary artery disease	1.67e-05	0.000339	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—AK1—coronary artery disease	1.62e-05	0.000329	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GCH1—coronary artery disease	1.62e-05	0.000329	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—coronary artery disease	1.62e-05	0.000329	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—AKR1B1—coronary artery disease	1.59e-05	0.000323	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—HK2—coronary artery disease	1.59e-05	0.000323	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PPAT—coronary artery disease	1.56e-05	0.000316	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PLCD1—coronary artery disease	1.56e-05	0.000316	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—UGCG—coronary artery disease	1.56e-05	0.000316	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—MDH2—coronary artery disease	1.56e-05	0.000316	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—SLC27A1—coronary artery disease	1.53e-05	0.00031	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CPT1B—coronary artery disease	1.5e-05	0.000304	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—LCAT—coronary artery disease	1.5e-05	0.000304	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PGM1—coronary artery disease	1.5e-05	0.000304	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—APOA4—coronary artery disease	1.47e-05	0.000299	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PYGB—coronary artery disease	1.45e-05	0.000294	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CKB—coronary artery disease	1.45e-05	0.000294	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—coronary artery disease	1.44e-05	0.000293	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PDHA1—coronary artery disease	1.42e-05	0.000288	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GCLM—coronary artery disease	1.42e-05	0.000288	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—APOB—coronary artery disease	1.38e-05	0.000279	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—TXNRD1—coronary artery disease	1.38e-05	0.000279	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CYP11B2—coronary artery disease	1.38e-05	0.000279	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PLIN1—coronary artery disease	1.36e-05	0.000276	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PFKFB3—coronary artery disease	1.36e-05	0.000276	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—DLAT—coronary artery disease	1.36e-05	0.000276	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—COX5B—coronary artery disease	1.36e-05	0.000276	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GSTM2—coronary artery disease	1.36e-05	0.000276	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—SLC22A3—coronary artery disease	1.36e-05	0.000275	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—HADH—coronary artery disease	1.34e-05	0.000271	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ARNTL—coronary artery disease	1.34e-05	0.000271	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—LPL—coronary artery disease	1.31e-05	0.000267	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—SULT1E1—coronary artery disease	1.29e-05	0.000262	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—coronary artery disease	1.28e-05	0.00026	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GPX2—coronary artery disease	1.27e-05	0.000257	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—APOA2—coronary artery disease	1.27e-05	0.000257	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PLA2G2A—coronary artery disease	1.27e-05	0.000257	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—SULT1A1—coronary artery disease	1.25e-05	0.000254	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ABCG5—coronary artery disease	1.25e-05	0.000254	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GPX4—coronary artery disease	1.25e-05	0.000254	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—HK1—coronary artery disease	1.25e-05	0.000254	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CD36—coronary artery disease	1.25e-05	0.000254	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—HADHA—coronary artery disease	1.24e-05	0.000251	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—AKR1B1—coronary artery disease	1.23e-05	0.00025	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—HK2—coronary artery disease	1.23e-05	0.00025	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GSTA1—coronary artery disease	1.22e-05	0.000248	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—LPA—coronary artery disease	1.21e-05	0.000245	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—SLC27A1—coronary artery disease	1.18e-05	0.000239	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PLCB3—coronary artery disease	1.17e-05	0.000237	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—APOA5—coronary artery disease	1.16e-05	0.000235	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CPT1B—coronary artery disease	1.16e-05	0.000235	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—LCAT—coronary artery disease	1.16e-05	0.000235	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—P4HB—coronary artery disease	1.14e-05	0.00023	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—APOA4—coronary artery disease	1.14e-05	0.00023	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	1.12e-05	0.000228	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PLA2G1B—coronary artery disease	1.11e-05	0.000226	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	1.1e-05	0.000224	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PDHA1—coronary artery disease	1.1e-05	0.000223	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GCLM—coronary artery disease	1.1e-05	0.000223	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	1.09e-05	0.000221	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—TXNRD1—coronary artery disease	1.06e-05	0.000216	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CYP11B2—coronary artery disease	1.06e-05	0.000216	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—VCAN—coronary artery disease	1.05e-05	0.000213	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—SLC22A3—coronary artery disease	1.05e-05	0.000212	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ALDOA—coronary artery disease	1.04e-05	0.000212	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—HADH—coronary artery disease	1.03e-05	0.000209	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ARNTL—coronary artery disease	1.03e-05	0.000209	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—DCN—coronary artery disease	1.01e-05	0.000205	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ALDH2—coronary artery disease	9.85e-06	0.0002	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GPX2—coronary artery disease	9.77e-06	0.000198	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	9.77e-06	0.000198	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—APOA2—coronary artery disease	9.77e-06	0.000198	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—HK1—coronary artery disease	9.65e-06	0.000196	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GPX4—coronary artery disease	9.65e-06	0.000196	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ABCG5—coronary artery disease	9.65e-06	0.000196	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—SULT1A1—coronary artery disease	9.65e-06	0.000196	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	9.6e-06	0.000195	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—LIPC—coronary artery disease	9.6e-06	0.000195	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—HBA1—coronary artery disease	9.6e-06	0.000195	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CYP2C19—coronary artery disease	9.6e-06	0.000195	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PIK3C2A—coronary artery disease	9.6e-06	0.000195	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—HADHA—coronary artery disease	9.54e-06	0.000194	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—APOC3—coronary artery disease	9.54e-06	0.000194	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—LDLR—coronary artery disease	9.48e-06	0.000192	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	9.47e-06	0.000192	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GSTA1—coronary artery disease	9.43e-06	0.000191	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—SLC9A1—coronary artery disease	9.37e-06	0.00019	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GSTT1—coronary artery disease	9.37e-06	0.00019	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—LPA—coronary artery disease	9.32e-06	0.000189	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CETP—coronary artery disease	9.26e-06	0.000188	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GCLC—coronary artery disease	9.26e-06	0.000188	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—SDC1—coronary artery disease	9.15e-06	0.000186	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PLCB3—coronary artery disease	9.03e-06	0.000183	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—APOA5—coronary artery disease	8.94e-06	0.000181	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—P4HB—coronary artery disease	8.77e-06	0.000178	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PSMB5—coronary artery disease	8.65e-06	0.000176	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PSMA6—coronary artery disease	8.65e-06	0.000176	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	8.63e-06	0.000175	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	8.6e-06	0.000175	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CTGF—coronary artery disease	8.45e-06	0.000171	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GOT2—coronary artery disease	8.37e-06	0.00017	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—HMGCR—coronary artery disease	8.37e-06	0.00017	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—VCAN—coronary artery disease	8.11e-06	0.000165	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ALDOA—coronary artery disease	8.05e-06	0.000163	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—DCN—coronary artery disease	7.81e-06	0.000159	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PLCB1—coronary artery disease	7.7e-06	0.000156	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ALDH2—coronary artery disease	7.6e-06	0.000154	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	7.55e-06	0.000153	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ABCA1—coronary artery disease	7.46e-06	0.000151	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—LIPC—coronary artery disease	7.41e-06	0.00015	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—HBA1—coronary artery disease	7.41e-06	0.00015	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	7.41e-06	0.00015	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CYP2C19—coronary artery disease	7.41e-06	0.00015	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—APOC3—coronary artery disease	7.36e-06	0.000149	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—LDLR—coronary artery disease	7.32e-06	0.000148	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—SLC9A1—coronary artery disease	7.23e-06	0.000147	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GSTT1—coronary artery disease	7.23e-06	0.000147	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GOT1—coronary artery disease	7.23e-06	0.000147	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GGT1—coronary artery disease	7.23e-06	0.000147	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GCLC—coronary artery disease	7.15e-06	0.000145	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CETP—coronary artery disease	7.15e-06	0.000145	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—SDC1—coronary artery disease	7.07e-06	0.000143	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PSMA6—coronary artery disease	6.67e-06	0.000135	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PSMB5—coronary artery disease	6.67e-06	0.000135	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CTGF—coronary artery disease	6.52e-06	0.000132	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GSTP1—coronary artery disease	6.49e-06	0.000132	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—HMGCR—coronary artery disease	6.46e-06	0.000131	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GOT2—coronary artery disease	6.46e-06	0.000131	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PPARGC1A—coronary artery disease	6.43e-06	0.000131	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—HMOX1—coronary artery disease	6.4e-06	0.00013	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CAT—coronary artery disease	6.32e-06	0.000128	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—APOB—coronary artery disease	6.13e-06	0.000124	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GSTM1—coronary artery disease	5.97e-06	0.000121	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PLCB1—coronary artery disease	5.94e-06	0.000121	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—LPL—coronary artery disease	5.86e-06	0.000119	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ABCA1—coronary artery disease	5.76e-06	0.000117	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GPX1—coronary artery disease	5.71e-06	0.000116	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GGT1—coronary artery disease	5.58e-06	0.000113	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GOT1—coronary artery disease	5.58e-06	0.000113	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CD36—coronary artery disease	5.56e-06	0.000113	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PPP2CA—coronary artery disease	5.49e-06	0.000112	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—MTHFR—coronary artery disease	5.27e-06	0.000107	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GSTP1—coronary artery disease	5.01e-06	0.000102	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—AGT—coronary artery disease	5.01e-06	0.000102	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	4.96e-06	0.000101	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—HMOX1—coronary artery disease	4.94e-06	0.0001	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—APOE—coronary artery disease	4.91e-06	9.96e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CAT—coronary artery disease	4.88e-06	9.9e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—APOA1—coronary artery disease	4.85e-06	9.85e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—APOB—coronary artery disease	4.73e-06	9.61e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	4.65e-06	9.43e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GSTM1—coronary artery disease	4.6e-06	9.34e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—LPL—coronary artery disease	4.52e-06	9.17e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GPX1—coronary artery disease	4.41e-06	8.95e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CD36—coronary artery disease	4.29e-06	8.72e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PPARG—coronary artery disease	4.28e-06	8.68e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PPP2CA—coronary artery disease	4.24e-06	8.61e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—POMC—coronary artery disease	4.22e-06	8.56e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—MTHFR—coronary artery disease	4.07e-06	8.26e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—AGT—coronary artery disease	3.87e-06	7.85e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ALB—coronary artery disease	3.84e-06	7.8e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—APOE—coronary artery disease	3.79e-06	7.69e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—APOA1—coronary artery disease	3.74e-06	7.6e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—NOS3—coronary artery disease	3.68e-06	7.46e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PTGS2—coronary artery disease	3.36e-06	6.83e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PPARG—coronary artery disease	3.3e-06	6.7e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—POMC—coronary artery disease	3.25e-06	6.6e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ALB—coronary artery disease	2.97e-06	6.02e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—NOS3—coronary artery disease	2.84e-06	5.76e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PTGS2—coronary artery disease	2.6e-06	5.27e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PIK3CA—coronary artery disease	2.07e-06	4.2e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—AKT1—coronary artery disease	1.69e-06	3.43e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PIK3CA—coronary artery disease	1.6e-06	3.24e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—AKT1—coronary artery disease	1.3e-06	2.65e-05	CbGpPWpGaD
